The anal cancer market is expanding as awareness of early diagnosis, screening, and treatment options continues to improve. Increasing attention toward human papillomavirus (HPV)-related cancers, advances in oncology, and the development of targeted and immune-based therapies are contributing to the evolving treatment landscape. Growing healthcare expenditure and improved access to cancer care...